NAMS
NewAmsterdam Pharma Company N.V.
$27.05
+$0.36(+1.35%)
50
Overall
--
Value
50
Tech
--
Quality
Market Cap
$2.76B
Volume
711.97K
52W Range
$14.06 - $27.35
Target Price
$41.50
EPS Estimates Overview
| Current Quarter | $-0.41 | Next Quarter | $-0.37 |
| Current Year | $-1.47 | Next Year | $-2.06 |
| QoQ Growth | +9.8% | YoY Growth | -40.1% |
| 3Y EPS CAGR | -63.3% | Target Price | $41.50 |
| Consensus | Buy | Upside | +53.4% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NAMS | $27.05 | +1.3% | 711.97K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get NewAmsterdam Pharma Company N.V. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW